- A cannabis será reclassificada até 31 de dezembro?11¢11%
The DEA administrative process for moving botanical marijuana from Schedule I to Schedule III remains in a limited briefing phase following an October 22 order from Chief ALJ Derek Julius. That ruling admitted a September GAO report highlighting gaps in federal scheduling procedures but denied requests to reopen the June-July 2026 hearings for additional testimony. Optional briefs on the report’s weight are due by November 5, after which the stay lifts and the judge can issue a nonbinding recommendation. An April 2026 Attorney General order already placed state-licensed medical marijuana and FDA-approved products into Schedule III, with the DEA issuing initial federal registrations to over 900 dispensaries in seven states as the first implementation step. Broader rescheduling covering adult-use cannabis requires the full hearing record, agency decision, and potential further review, keeping near-term resolution unlikely.
Regras
Este mercado será resolvido como "Sim" se a Drug Enforcement Administration dos Estados Unidos (https://www.dea.gov/drug-information/drug-scheduling) reclassificar a maconha, retirando-a do nível I para qualquer outro nível (ou desclassificando-a completamente), até 31 de dezembro de 2026, às 23:59 ET. Caso contrário, este mercado será resolvido como "Não". A principal fonte para a resolução deste mercado serão informações oficiais do governo dos EUA; no entanto, também será usado um consenso de reportagens confiáveis.
Tradução automática. Em caso de divergência, prevalece o original.